Follow
Jonathan Dyke
Jonathan Dyke
Weill Cornell Medicine
Verified email at med.cornell.edu - Homepage
Title
Cited by
Cited by
Year
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
S Worgall, D Sondhi, NR Hackett, B Kosofsky, MV Kekatpure, N Neyzi, ...
Human gene therapy 19 (5), 463-474, 2008
4662008
The medial prefrontal cortex and the emergence of self-conscious emotion in adolescence
LH Somerville, RM Jones, EJ Ruberry, JP Dyke, G Glover, BJ Casey
Psychological science 24 (8), 1554-1562, 2013
4292013
Study of intraventricular cerliponase alfa for CLN2 disease
A Schulz, T Ajayi, N Specchio, E de Los Reyes, P Gissen, D Ballon, ...
New England Journal of Medicine 378 (20), 1898-1907, 2018
4162018
Possible axonal regrowth in late recovery from the minimally conscious state
HU Voss, AM UluÁ, JP Dyke, R Watts, EJ Kobylarz, BD McCandliss, ...
The Journal of clinical investigation 116 (7), 2005-2011, 2006
4032006
Dissociations between behavioural and functional magnetic resonance imaging-based evaluations of cognitive function after brain injury
JC Bardin, JJ Fins, DI Katz, J Hersh, LA Heier, K Tabelow, JP Dyke, ...
Brain 134 (3), 769-782, 2011
3232011
Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism
SA Stanley, L Kelly, KN Latcha, SF Schmidt, X Yu, AR Nectow, J Sauer, ...
Nature 531 (7596), 647-650, 2016
2572016
Audio-visual multisensory integration in superior parietal lobule revealed by human intracranial recordings
S Molholm, P Sehatpour, AD Mehta, M Shpaner, M Gomez-Ramirez, ...
Journal of neurophysiology 96 (2), 721-729, 2006
2452006
Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology
DC Shungu, N Weiduschat, JW Murrough, X Mao, S Pillemer, JP Dyke, ...
NMR in Biomedicine 25 (9), 1073-1087, 2012
2352012
Quantitative assessment of the vascularity of the proximal part of the humerus
CM Hettrich, S Boraiah, JP Dyke, A Neviaser, DL Helfet, DG Lorich
JBJS 92 (4), 943-948, 2010
2342010
Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging
M Zaider, MJ Zelefsky, EK Lee, KL Zakian, HI Amols, J Dyke, G Cohen, ...
International Journal of Radiation Oncology* Biology* Physics 47 (4), 1085-1096, 2000
1732000
Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging
JP Dyke, DM Panicek, JH Healey, PA Meyers, AG Huvos, LH Schwartz, ...
Radiology 228 (1), 271-278, 2003
1682003
Adolescent-specific patterns of behavior and neural activity during social reinforcement learning
RM Jones, LH Somerville, J Li, EJ Ruberry, A Powers, N Mehta, J Dyke, ...
Cognitive, Affective, & Behavioral Neuroscience 14, 683-697, 2014
1532014
Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late†…
RG Crystal, D Sondhi, NR Hackett, SM Kaminsky, S Worgall, P Stieg, ...
Human gene therapy 15 (11), 1131-1154, 2004
1462004
Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning
GW Kabalka, GT Smith, JP Dyke, WS Reid, CPD Longford, TG Roberts, ...
Journal of Nuclear Medicine 38 (11), 1762-1767, 1997
1261997
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis
S Worgall, MV Kekatpure, L Heier, D Ballon, JP Dyke, D Shungu, X Mao, ...
Neurology 69 (6), 521-535, 2007
1182007
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition
L Mosconi, V Berti, J Dyke, E Schelbaum, S Jett, L Loughlin, G Jang, ...
Scientific reports 11 (1), 10867, 2021
1152021
AAVrh. 10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer's disease
JB Rosenberg, MG Kaplitt, BP De, A Chen, T Flagiello, C Salami, E Pey, ...
Human Gene Therapy Clinical Development 29 (1), 24-47, 2018
1142018
Sex-driven modifiers of Alzheimer risk: a multimodality brain imaging study
A Rahman, E Schelbaum, K Hoffman, I Diaz, H Hristov, R Andrews, S Jett, ...
Neurology 95 (2), e166-e178, 2020
1132020
Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in†…
M Ishii, G Wang, G Racchumi, JP Dyke, C Iadecola
Journal of Neuroscience 34 (27), 9096-9106, 2014
1072014
Imaging therapeutic response in human bone marrow using rapid whole‐body MRI
D Ballon, R Watts, JP Dyke, E Lis, MJ Morris, HI Scher, AM Uluğ, ...
Magnetic Resonance in Medicine: An Official Journal of the International†…, 2004
1072004
The system can't perform the operation now. Try again later.
Articles 1–20